Johnson & Johnson's stock rallies on profit result, upbeat outlook [MarketWatch]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: MarketWatch
Johnson & Johnson's stock rallies after profit beat expectations, provides upbeat outlook Shares of Johnson & Johnson JNJ, +0.53% rallied 1.0% in premarket trade Tuesday, after the health care and consumer products company reported fourth-quarter profit that beat expectations, and provided an upbeat outlook. The company swung to a net loss of $10.71 billion, or $3.99 a share, from earnings of $3.81 billion, or $1.38 a share, in the same period a year ago. Excluding non-recurring items, which included a charge related to recent tax legislation, adjusted earnings per share came to $1.74, above the FactSet consensus of $1.72. Revenue rose 11.5% to $20.20 billion, beating the FactSet consensus of $20.08 billion. Consumer revenue rose 3.1% to $3.54, just shy of the FactSet consensus of $3.56 billion, while pharmaceutical revenue grew 17.6% to $9.68 billion to top expectations of $9.66 billion and medical devices revenue increased 8.3% to $6.97 billion to beat expectations of $6.90 billi
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Antispasmodics Drugs: Global Market Analysis and Forecast 2018-2033 Featuring Daiichi Sankyo Company, Fresenius Kabi, Hikma Pharma, Johnson & Johnson Services, Pfizer, and Other Key Players [Yahoo! Finance]Yahoo! Finance
- Xaira Therapeutics Launches to Deliver Transformative Medicines by Advancing and Harnessing AI for Drug Discovery and Development [Yahoo! Finance]Yahoo! Finance
- Artificial Joints Market to Reach $32.57 Billion by 2033; Rising Prevalence of Sedentary Lifestyle to Propel Growth [Yahoo! Finance]Yahoo! Finance
- Ethereum price today: ETH is trading at $3,179.50 [USA TODAY]USA TODAY
- AMSilk strengthens management team with key hires of Ralph Fraundorfer and Ctibor Kohutovic to Management Board [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 4/16/24 - Form 8-K/A
- 4/16/24 - Form 8-K
- 3/27/24 - Form PX14A6G
- JNJ's page on the SEC website